221 related articles for article (PubMed ID: 24535317)
1. Benefit of tumor resection for recurrent glioblastoma.
Quick J; Gessler F; Dützmann S; Hattingen E; Harter PN; Weise LM; Franz K; Seifert V; Senft C
J Neurooncol; 2014 Apr; 117(2):365-72. PubMed ID: 24535317
[TBL] [Abstract][Full Text] [Related]
2. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
3. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
4. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
[TBL] [Abstract][Full Text] [Related]
5. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
6. Multiple resections for patients with glioblastoma: prolonging survival.
Chaichana KL; Zadnik P; Weingart JD; Olivi A; Gallia GL; Blakeley J; Lim M; Brem H; Quiñones-Hinojosa A
J Neurosurg; 2013 Apr; 118(4):812-20. PubMed ID: 23082884
[TBL] [Abstract][Full Text] [Related]
7. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
[TBL] [Abstract][Full Text] [Related]
8. Resection of recurrent glioblastoma multiforme in elderly patients: a pseudo-randomized analysis revealed clinical benefit.
Fariña Nuñez MT; Franco P; Cipriani D; Neidert N; Behringer SP; Mader I; Delev D; Fung C; Beck J; Sankowski R; Nicolay NH; Heiland DH; Schnell O
J Neurooncol; 2020 Jan; 146(2):381-387. PubMed ID: 31933259
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
[TBL] [Abstract][Full Text] [Related]
10. Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.
Chen MW; Morsy AA; Liang S; Ng WH
World Neurosurg; 2016 Mar; 87():439-45. PubMed ID: 26585720
[TBL] [Abstract][Full Text] [Related]
11. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
12. Impact of resection on overall survival of recurrent Glioblastoma in elderly patients.
Hager J; Herrmann E; Kammerer S; Dinc N; Won SY; Senft C; Seifert V; Marquardt G; Quick-Weller J
Clin Neurol Neurosurg; 2018 Nov; 174():21-25. PubMed ID: 30195896
[TBL] [Abstract][Full Text] [Related]
13. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
[TBL] [Abstract][Full Text] [Related]
14. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
[TBL] [Abstract][Full Text] [Related]
16. Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.
Sughrue ME; Sheean T; Bonney PA; Maurer AJ; Teo C
Neurosurg Focus; 2015 Mar; 38(3):E11. PubMed ID: 25727220
[TBL] [Abstract][Full Text] [Related]
17. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
[TBL] [Abstract][Full Text] [Related]
18. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
Chaichana KL; Jusue-Torres I; Navarro-Ramirez R; Raza SM; Pascual-Gallego M; Ibrahim A; Hernandez-Hermann M; Gomez L; Ye X; Weingart JD; Olivi A; Blakeley J; Gallia GL; Lim M; Brem H; Quinones-Hinojosa A
Neuro Oncol; 2014 Jan; 16(1):113-22. PubMed ID: 24285550
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
20. Survival after reoperation for recurrent glioblastoma.
Woodroffe RW; Zanaty M; Soni N; Mott SL; Helland LC; Pasha A; Maley J; Dhungana N; Jones KA; Monga V; Greenlee JDW
J Clin Neurosci; 2020 Mar; 73():118-124. PubMed ID: 31987636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]